Verastem reported $831K in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Curis USD 806K 9K Sep/2023
Cytokinetics USD 10.25M 2.75M Sep/2025
Gilead Sciences USD 88M 15M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
Pfizer USD 0.62 156M Sep/2025
Verastem USD 831K 1.04M Sep/2024